Hinge Health Class A (HNGE) closed at $111.52 on October 23, 2026, up 1.4% from the previous close, on volume of 1,290,181 shares (30-day average 1,891,957).
Data as of October 23, 2026.
23-Oct-2026
Hinge Health to announce third quarter 2026 financial results on November 2, 2026
Business Wire (Mon, 5-Oct 12:00 PM ET)
Hinge Health to acquire Cylinder Health, expanding into gastrointestinal care
Business Wire (Tue, 4-Aug 4:05 PM ET)
Business Wire (Tue, 4-Aug 4:05 PM ET)
Study finds Hinge Health significantly lowers fall risk for adults aged 65+
Business Wire (Thu, 30-Jul 9:05 AM ET)
Hinge Health Sets Record Revenue and Cash Flow, Raises Full-Year Outlook on Strong Platform Momentum
Market Chameleon (Wed, 6-May 6:38 AM ET)
Hinge Health Delivers Record 2025 Growth With Expanding Margins and Robust Client Metrics
Market Chameleon (Wed, 11-Feb 5:37 AM ET)
HNGE Delivers Record Results: Revenue Up 51%, Margins Climb, and Member Growth Accelerates
Market Chameleon (Wed, 11-Feb 2:37 AM ET)
Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain. Through a combination of AI-powered motion tracking technology, the Company's platform helps members address chronic musculoskeletal (MSK) conditions, enables improved member outcomes and supports cost reductions for its clients.
Hinge Health Class A trades on the NYSE stock market under the symbol HNGE.
As of October 23, 2026, HNGE stock price climbed to $111.52 with 1,290,181 million shares trading.
HNGE has a beta of 1.33, meaning it tends to be more sensitive to market movements. HNGE has a correlation of 0.06 to the broad based SPY ETF.
HNGE has a market cap of $8.63 billion. This is considered a Mid Cap stock.
Last quarter Hinge Health Class A reported $213 million in Revenue and $.59 earnings per share. This beat revenue expectation by $12 million and exceeded earnings estimates by $.04.
The top ETF exchange traded funds that HNGE belongs to (by Net Assets): VTI, VB, IWM, VXF, IWO.
HNGE has outperformed the market in the last year with a price return of +125.1% while the SPY ETF gained +14.3%. HNGE has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +45.4% and +8.4%, respectively, while the SPY returned +3.2% and -2.4%, respectively.
HNGE support price is $106.61 and resistance is $113.26 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HNGE shares will trade within this expected range on the day.
